Press release
Asia-Pacific IBD Therapeutics Market Segmentation, Forecast, Analysis, Industry Size and Share to 2025
Asia-Pacific IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.5% during the forecast period. The major economies which are contributing to the market are China, India, and Japan. The market growth in these countries is mainly attributed to the growing healthcare infrastructure due to substantial government spending in the healthcare sector. Rapid urbanization and changing eating habits are also supposed to grow the market substantially in the region.Request a Free Sample of our Report on Asia-Pacific IBD Therapeutics Market: https://www.omrglobal.com/request-sample/asia-pacific-ibd-inflammatory-bowel-disease-therapeutics-market
Japan contributes significantly to the IBD market in the Asia-Pacific due to growing awareness about IBD and the established healthcare industry. Along with these economies, Australia, Indonesia, and Thailand are other major regions with advanced healthcare facilities and will show a significant growth rate during the forecasted period.
Asia-Pacific IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis.
For Crohn's and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.
A Full Report of Asia-Pacific IBD Therapeutics Market is Available at https://www.omrglobal.com/industry-reports/asia-pacific-ibd-inflammatory-bowel-disease-therapeutics-market
Asia-Pacific IBD Therapeutics Market
By Disease Type
o Ulcerative Colitis
o Crohn's Disease
By Treatment Type
o Surgery
o Anti- Inflammatory Drug Administration
o Steroids
o Immunosuppressant
o Biological Drugs
o Amino salicylates
o Others
Regional Analysis
o China
o India
o Japan
o Rest of Asia-Pacific
Company Profiles
o AbbVie Inc.
o Allergan, PLC
o Boehringer Ingelheim International GmbH
o Daiichi Sankyo Co. Ltd.
o Eli Lilly and Co.
o Johnson & Johnson Services Inc.
o Mercator Pharmaceutical Solutions
o Pfizer Inc.
o RPG Life Sciences Ltd.
o Sanofi S.A.
o Takeda Pharmaceutical Co., Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-ibd-inflammatory-bowel-disease-therapeutics-market
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific IBD Therapeutics Market Segmentation, Forecast, Analysis, Industry Size and Share to 2025 here
News-ID: 1965908 • Views: …
More Releases from Orion Market Research
Advanced Process Control (APC) Market Size, Trends, Latest Insights, Analysis an …
The global Advanced Process Control (APC) market is estimated to grow at a CAGR of 9.5% during the forecast period (2024-2031). The market growth is driven by the rising automation across industries and the growing oil and gas industry. Additionally, governments across various regions are working towards the integration of advanced solutions and modernizing industrial infrastructure. For instance, the government of China has launched the Made in China (MIC) 2025…
MRSA Antibiotic Market Size, Trends, Latest Insights, Analysis and Forecast 2024 …
The global MRSA antibiotic market is anticipated to grow at a considerable CAGR of 5.5% during the forecast. The major factors attributing to the growth of the MRSA drugs market are the rise in the global prevalence of MRSA infections and increasing private and public funding for R&D with regards to novel anti-MRSA drugs. For instance, in January 2020, Wockhardt announced regulatory approval to two antibiotics EMROK (IV) and EMROK…
E-Cigarette Market Size, Trends, Latest Insights, Analysis and Forecast 2024-203 …
The global e-cigarette market is anticipated to grow at a significant CAGR of 17.3% during the forecast period. The e-cigarette has been around for a while and it has gained a lot of attention in the past few years as an alternative to smoking. It offers some of the difference which makes it a better option, ultimately growing the demand across the globe. There are several differences between cigarettes and…
Dental Implants Market is Dazzling Worldwide and Forecast to 2031
The global dental implant market is anticipated to grow at a significant CAGR of 7.5% during the forecast period (2024-2031). The market growth is primarily driven by the rising incidence of tooth loss, high demand for aesthetic dentistry, and the growing per capita healthcare spending. Also, the increasing patient pool for dental treatments is driving industry growth. Additionally, the consolidation of dental practices and rising DSO activities are presenting opportunities…
More Releases for IBD
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per…
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For …
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunity…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,…
